864 related articles for article (PubMed ID: 26536459)
21. Network-based meta-analysis in the identification of biomarkers for papillary thyroid cancer.
Zhao H; Li H
Gene; 2018 Jun; 661():160-168. PubMed ID: 29625265
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of a set of microRNA genes reveals the potential mechanism of papillary thyroid carcinoma.
Feng Z; Song Y; Qian J; Chen T; Yang C; Jia L; Liu C; Liu P; Lv J; Deng Z
Ann Endocrinol (Paris); 2019 Apr; 80(2):77-83. PubMed ID: 30685058
[TBL] [Abstract][Full Text] [Related]
23. MiRNA expression may account for chronic but not for acute regulation of mRNA expression in human thyroid tumor models.
Floor SL; Hebrant A; Pita JM; Saiselet M; Trésallet C; Libert F; Andry G; Dumont JE; van Staveren WC; Maenhaut C
PLoS One; 2014; 9(11):e111581. PubMed ID: 25375362
[TBL] [Abstract][Full Text] [Related]
24. Identifying cancer-related microRNAs based on gene expression data.
Zhao XM; Liu KQ; Zhu G; He F; Duval B; Richer JM; Huang DS; Jiang CJ; Hao JK; Chen L
Bioinformatics; 2015 Apr; 31(8):1226-34. PubMed ID: 25505085
[TBL] [Abstract][Full Text] [Related]
25. Genome-wide expression analysis suggests a crucial role of dysregulation of matrix metalloproteinases pathway in undifferentiated thyroid carcinoma.
Espinal-Enríquez J; Muñoz-Montero S; Imaz-Rosshandler I; Huerta-Verde A; Mejía C; Hernández-Lemus E
BMC Genomics; 2015 Mar; 16(1):207. PubMed ID: 25887408
[TBL] [Abstract][Full Text] [Related]
26. Micro-RNAs in thyroid neoplasms: molecular, diagnostic and therapeutic implications.
Menon MP; Khan A
J Clin Pathol; 2009 Nov; 62(11):978-85. PubMed ID: 19625289
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma.
Rossing M; Borup R; Henao R; Winther O; Vikesaa J; Niazi O; Godballe C; Krogdahl A; Glud M; Hjort-Sørensen C; Kiss K; Bennedbæk FN; Nielsen FC
J Mol Endocrinol; 2012 Feb; 48(1):11-23. PubMed ID: 22049245
[TBL] [Abstract][Full Text] [Related]
28. The miR-146b-3p/PAX8/NIS Regulatory Circuit Modulates the Differentiation Phenotype and Function of Thyroid Cells during Carcinogenesis.
Riesco-Eizaguirre G; Wert-Lamas L; Perales-Patón J; Sastre-Perona A; Fernández LP; Santisteban P
Cancer Res; 2015 Oct; 75(19):4119-30. PubMed ID: 26282166
[TBL] [Abstract][Full Text] [Related]
29. Expression of MicroRNAs in Thyroid Carcinoma.
Zhu G; Xie L; Miller D
Methods Mol Biol; 2017; 1617():261-280. PubMed ID: 28540691
[TBL] [Abstract][Full Text] [Related]
30. Role of microRNAs in endocrine cancer metastasis.
Lima CR; Gomes CC; Santos MF
Mol Cell Endocrinol; 2017 Nov; 456():62-75. PubMed ID: 28322989
[TBL] [Abstract][Full Text] [Related]
31. Dissecting the biological relationship between TCGA miRNA and mRNA sequencing data using MMiRNA-Viewer.
Bai Y; Ding L; Baker S; Bai JM; Rath E; Jiang F; Wu J; Jiang H; Stuart G
BMC Bioinformatics; 2016 Oct; 17(Suppl 13):336. PubMed ID: 27766936
[TBL] [Abstract][Full Text] [Related]
32. Preserved SCN4B expression is an independent indicator of favorable recurrence-free survival in classical papillary thyroid cancer.
Gong Y; Yang J; Wu W; Liu F; Su A; Li Z; Zhu J; Wei T
PLoS One; 2018; 13(5):e0197007. PubMed ID: 29723302
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.
Zhang X; Li D; Li M; Ye M; Ding L; Cai H; Fu D; Lv Z
Int J Cancer; 2014 Jan; 134(2):257-67. PubMed ID: 23457043
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive gene and microRNA expression profiling reveals a role for miRNAs in the oncogenic roles of SphK1 in papillary thyroid cancer.
Liang W; Xie Z; Cui W; Guo Y; Xu L; Wu J; Guan H
J Cancer Res Clin Oncol; 2017 Apr; 143(4):601-611. PubMed ID: 27942860
[TBL] [Abstract][Full Text] [Related]
36. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
37. Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?
Lassalle S; Hofman V; Ilie M; Bonnetaud C; Puisségur MP; Brest P; Loubatier C; Guevara N; Bordone O; Cardinaud B; Lebrigand K; Rios G; Santini J; Franc B; Mari B; Al Ghuzlan A; Vielh P; Barbry P; Hofman P
Endocr Relat Cancer; 2011 Oct; 18(5):579-94. PubMed ID: 21778212
[TBL] [Abstract][Full Text] [Related]
38. Identifying key genes of classic papillary thyroid cancer in women aged more than 55 years old using bioinformatics analysis.
Li CC; Ullah MHE; Lin X; Shan SK; Guo B; Zheng MH; Wang Y; Li F; Yuan LQ
Front Endocrinol (Lausanne); 2022; 13():948285. PubMed ID: 36120433
[TBL] [Abstract][Full Text] [Related]
39. An 8 miRNA-Based Risk Score System for Predicting the Prognosis of Patients With Papillary Thyroid Cancer.
Yi W; Liu J; Qu S; Fan H; Lv Z
Technol Cancer Res Treat; 2020; 19():1533033820965594. PubMed ID: 33054579
[TBL] [Abstract][Full Text] [Related]
40. Expressions of miRNAs in papillary thyroid carcinoma and their associations with the BRAFV600E mutation.
Huang Y; Liao D; Pan L; Ye R; Li X; Wang S; Ye C; Chen L
Eur J Endocrinol; 2013 May; 168(5):675-81. PubMed ID: 23416953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]